Characteristics | No of patients (%) |
---|---|
Age | Â |
Median | 44 |
Range | 37-66 |
Gender | Â |
Male | 12 (80.0%) |
Female | 3 (20.0%) |
Histology | Â |
WHO I | 0 (0.0%) |
WHO II/III | 15 (100.0%) |
T stage* | Â |
T1 | 1 (6.7%) |
T2 | 5 (33.3%) |
T3 | 9 (60.0%) |
T4 | 0 (0.0%) |
N stage* | Â |
N0 | 3 (20.0%) |
N1 | 7 (46.7%) |
N2 | 4 (26.7%) |
N3 | 1 (6.7%) |
Clinical stage* | Â |
I | 1 (6.7%) |
II | 2 (13.3%) |
III | 11 (73.3%) |
IV | 1 (6.7%) |
Chemotherapy | Â |
No | 3 (20.0%) |
Yes | 12 (80.0%) |